WeArable teChnology daTa driVen digitAl healTh cOachINg (ACTIVATION)- A Mixed-methods Study

NCT06752772 · tracked via the Priya Life Science Singapore tracker

Sponsor

Alexandra Hospital

Phase

Not applicable

Started

2024-08-06

Last updated

2025-10-02

Condition(s) studied

Elevated Blood PressureHypertensionOverweight/ObesityType 2 Diabetes Mellitus (T2DM)HyperlipidemiaPrediabetes

Investigational drug(s) / intervention(s)

Smart watchDashboard with nudging systemDigital Health Coach (DHC)

Smart watch: Participants are required to wear the study issued smart watch for at least 8 hours a day during the intervention period and are encouraged to wear it beyond the study intervention period.

Dashboard with nudging system: Nudges will be sent to participants' smart watch/mobile application with messages that are designed to motivate them to lead a healthy lifestyle.

Digital Health Coach (DHC): Participants will be assigned to a DHC and the DHC will be providing them with remote health coaching assistance for a duration of 6 months, upon successful enrolment.

Study summary

Public health priorities have shifted towards disease prevention, emphasising health promotion and lifestyle interventions to reduce disease burden. Despite global efforts, the prevalence of chronic diseases remains high, with lifestyle factors such as alcohol consumption, diet, smoking, obesity, and sedentary behaviour playing significant roles. In Singapore, suboptimal lifestyle behaviours are common, contributing to a high incidence of chronic conditions. Metabolic syndrome (MetS), linked to obesity, poses a growing societal burden due to its association with cardiovascular risks. Disparities exist in the delivery of lifestyle interventions among healthcare providers (HCPs), with many patients receiving inadequate guidance. Digital health coaching, incorporating wearable technology, offers promising solutions to bridge these gaps, providing personalised, real-time support and feedback to improve lifestyle behaviours and prevent disease progression. Challenges such as time constraints, lack of feedback, and limited support can be addressed through remote monitoring and tailored interventions, making scalable population-level interventions feasible.

Eligibility

Sex

ALL

Min age

21 Years

Max age

75 Years

Healthy volunteers

Inclusion Criteria: * 21-75 years old * Patients who are at risk of any of the following: 1. Elevated blood pressure 2. Overweight (BMI\>=23kg/m2) 3. Pre-diabetes, OR * Patients who have one or more of the following (HOLD) conditions: 1. Hypertension 2. Obesity (BMI\>=27.5kg/m2) 3. HyperLipidemia 4. Type 2 Diabetes Mellitus * Patients who own a smartphone * Patients who are willing to wear a smartwatch during the intervention period. Exclusion Criteria: * Patients who have a medical condition that prevented participation in physical activity * Patients who have current diagnosis or history of eating disorder, depression * Patients who are currently pregnant or planning to become pregnant in the next 6 months * Patients who are currently participating in a weight loss programme (commercial, medically supervised, or research study) * Patients who are on weight loss medications (over-the-counter or prescription) * Patients who are not mentally-, physically- or technologically-capable * Patients who is unable to provide informed consent.

Primary outcome measure(s)

Changes in physical activity level — Baseline, 6- and 12-month post study enrolment
Change in physical activity level will be measured using the International Physical Activity Questionnaire Short Form (IPAQ-SF) scale at baseline, 6- and 12-month post study enrolment. Higher score indicates a higher level of physical activity.

Trial sites (1)

Facility	City	Region	Status
Alexandra Hospital	Singapore	Singapore	Recruiting

More Alexandra Hospital trials in Singapore

Tailored Brain Health Insights Through Nurturing Knowledge-based Change - Stakeholder-driven, Human-centered, AI-powered Refinement for Prevention Starting soon

Nurse-led Physician-supported Care for Patients With Chronic Kidney Disease and Multimorbidity Recruiting

Other trials for the same condition

A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension Enrolling by invitation

Sodium-rich COndiments Unifying Health and Taste Recruiting

Colchicine for Primary Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Recruiting

Sodium Storage in Singaporeans Active, not recruiting

Addressing Medication Non-adherence in Patients With Poorly Controlled Hypertension Using Urine Mass Spectrometry Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06752772 on ClinicalTrials.gov ↗ ← All trials in Singapore